Argatroban as a Aubstitute of Heparin During Cardiopulmonary Bypass: A Safe Alternative?
The objective of this communication is to report our recent experience with this agent during cardiopulmonary bypass (CPB) and to review the cases previously published in order to better define indications, dosage, monitoring and limitations in cardiac surgery patients.